ANA
ARIZCORRETA YARZA
Profesora asociada de Ciencias de la Salud
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (5)
2008
-
Role of pegylated interferon-α-2a and ribavirin concentrations in sustained viral response in HCV/HIV-coinfected patients
Clinical Pharmacology and Therapeutics, Vol. 84, Núm. 5, pp. 573-580
2007
-
Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients
Antiviral Therapy, Vol. 12, Núm. 8, pp. 1225-1235
-
Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients
Antiviral Therapy, Vol. 12, Núm. 4, pp. 523-529
2006
-
Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C
Antiviral Therapy, Vol. 11, Núm. 7, pp. 839-846
-
Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C
Journal of Antimicrobial Chemotherapy, Vol. 58, Núm. 1, pp. 140-146